Walmart-backed technology firm Ibotta files to go public in US-February 2024-www.financetom.com

Walmart-backed technology firm Ibotta files to go public in US

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Walmart-backed technology firm Ibotta files to go public in US

Mar 22, 2024 12:36 PM

March 22 (Reuters) - Walmart ( WMT )-backed Ibotta has

filed to go public in the United States, the technology company

said in a filing on Friday.

(Reporting by Mehnaz Yasmin in Bengaluru)

Previous page： BRIEF-JanOne to Acquire ALT 5 Sigma Inc Next page： Apple Facing Potential Strike at Towson, Maryland Store

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-JanOne to Acquire ALT 5 Sigma Inc

May 13, 2024

May 13 (Reuters) - Janone Inc ( JAN ): * JANONE TO ACQUIRE ALT 5 SIGMA INC., A LEADING NEXT GENERATION BLOCKCHAIN FINANCIAL TECHNOLOGY PROVIDER * JANONE TO ISSUE 1.8M SHARES TO FORMER ALT 5 STOCKHOLDERS Source text for Eikon: Further company coverage: ...

Apple Facing Potential Strike at Towson, Maryland Store

May 13, 2024

07:46 AM EDT, 05/13/2024 (MT Newswires) -- Apple ( AAPL ) is facing a potential strike at its retail store in Towson, Maryland after members of the International Association of Machinists and Aerospace Workers' Coalition of Organized Retail Employees, or IAM CORE, voted in favor of authorizing a labor action, the union said in a Saturday statement. IAM CORE represents...

BRIEF-Reneo Pharmaceuticals and OnKure Announce Proposed Merger

May 13, 2024

May 13 (Reuters) - Reneo Pharmaceuticals Inc ( RPHM ): * RENEO PHARMACEUTICALS AND ONKURE ANNOUNCE PROPOSED MERGER * RENEO PHARMACEUTICALS INC ( RPHM ) - MERGER TO CREATE A NASDAQ-LISTED, CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY * RENEO PHARMACEUTICALS INC ( RPHM ) - MERGED COMPANY TO BE NAMED ONKURE THERAPEUTICS * RENEO PHARMACEUTICALS ( RPHM ): COMBINED CO EXPECTED TO OPERATE...

Burford Capital Swings to Q1 Net Loss, Revenue Drops

May 13, 2024

07:53 AM EDT, 05/13/2024 (MT Newswires) -- Burford Capital ( BUR ) reported a Q1 net loss Monday of $0.14 per diluted share, swinging from net income of $1.17 per share a year earlier. Two analysts polled by Capital IQ expected earnings of $0.45 per share. Revenue for the quarter ended March 31 was $44.3 million, down from $380.9 million...